4DMedicalFDMDF -6.67%46 Debt-to-Equity is -0.36 as of Dec. 2025. GuruFocus rates FDMDF with a GF Score™ of 46/100 and a GF Value™ of $0.87 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 704 Medical Devices & Instruments companies, 4DMedical ranks worse than 142045.31% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for 4DMedical's Debt-to-Equity or its related term are showing as below:
FDMDF'
s Debt-to-Equity Range Over the Past 10 Years
Min: -1.53 Med: 0.05 Max: 0.13
Current: -0.36
During the past 6 years, the highest Debt-to-Equity Ratio of 4DMedical was 0.13. The lowest was -1.53. And the median was 0.05.
FDMDF's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.225
vs FDMDF: -0.36
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
4DMedical Debt-to-Equity Related Terms
4DMedical Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for 4DMedical's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 4DMedical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4DMedical Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where 4DMedical's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4DMedical (FDMDF) has a Debt-to-Equity of -0.36 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on 4DMedical and its competitors. According to the industry distribution chart, 4DMedical ranks #999999 out of 704 companies in the Medical Devices & Instruments industry.
Is 4DMedical's Debt-to-Equity too high?
4DMedical's current Debt-to-Equity is -0.36. Based on the distribution chart, 4DMedical ranks #999999 out of 704 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, 4DMedical has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's Debt-to-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 4DMedical ranks #999999 out of 704 companies for Debt-to-Equity. This places 4DMedical in the lower half of its industry. The industry median Debt-to-Equity is 0.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on 4DMedical and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4DMedical's current Debt-to-Equity is -0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (FDMDF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.87, compared to a current price of $2.80 — trading 221.8% above its estimated fair value. The current Debt-to-Equity is -0.36. 4DMedical's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For 4DMedical (FDMDF), the current Debt-to-Equity is -0.36 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 4DMedical (FDMDF) Overvalued in 2026?
Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued.
The current stock price of $2.80 is trading 221.8% above its estimated GF Value™ of $0.87.
GuruFocus considers 4DMedical to be Significantly Overvalued.
Key valuation signals for FDMDF:
Debt-to-Equity: -0.36
GF Value™: $0.87 vs. price of $2.80 (221.8% above fair value)
No single metric tells the full story. See the FDMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
46GF Score
Get the complete analysis for FDMDF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FDMDF has been successfully added to your 
